397 Shares in Chemed Co. (NYSE:CHE) Acquired by Brogan Financial Inc.

Brogan Financial Inc. acquired a new stake in shares of Chemed Co. (NYSE:CHE) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 397 shares of the company’s stock, valued at approximately $210,000.

Several other large investors have also recently bought and sold shares of the company. HighTower Advisors LLC increased its position in shares of Chemed by 78.0% in the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock valued at $2,246,000 after buying an additional 1,634 shares in the last quarter. Quantinno Capital Management LP grew its stake in Chemed by 29.9% in the third quarter. Quantinno Capital Management LP now owns 1,587 shares of the company’s stock valued at $954,000 after acquiring an additional 365 shares during the period. National Bank of Canada FI bought a new stake in shares of Chemed in the third quarter worth about $1,496,000. MML Investors Services LLC raised its position in shares of Chemed by 3.9% during the third quarter. MML Investors Services LLC now owns 1,457 shares of the company’s stock worth $876,000 after purchasing an additional 55 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of Chemed by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after purchasing an additional 15,791 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 3.32% of the company’s stock.

Analysts Set New Price Targets

CHE has been the subject of a number of research reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada raised their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Chemed Price Performance

Shares of Chemed stock opened at $591.44 on Friday. The firm has a market cap of $8.64 billion, a price-to-earnings ratio of 29.89, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. Chemed Co. has a one year low of $512.12 and a one year high of $625.09. The stock’s 50-day moving average is $583.16 and its 200-day moving average is $567.95.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is currently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.